A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells

被引:228
|
作者
Yu, Aixin [1 ]
Zhu, Linjian [1 ]
Altman, Norman H. [2 ]
Malek, Thomas R. [1 ,3 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33101 USA
[3] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA
关键词
LETHAL AUTOIMMUNITY; STAT5; ACTIVATION; FOXP3; EXPRESSION; TGF-BETA; IL-2; RECEPTOR; MICE; INDUCTION; EXPANSION; CYTOKINE;
D O I
10.1016/j.immuni.2008.11.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-2 receptor (IL-2R) signaling is essential for T regulatory (Treg) cell development and homeostasis. Here, we show that expression of IL-2R beta chains that lack tyrosine residues important for the association of the adaptor Shc and the transcription factor STAT5 in IL-2R beta-deficient mice resulted in production of a normal proportion of natural Treg cells that suppressed severe autoimmunity related with deficiency in IL-2 or IL-2R. These mutant IL-2R beta chains supported suboptimal and transient STAT5 activation that upregulate the transcription factor Foxp3 to normal amounts in natural, but not induced, Treg cells. Nevertheless, gene expression profiling revealed many targets in peripheral natural Treg cells that were IL-2 dependent and a substantial overlap between the Treg cell IL-2-dependent gene program and the Treg cell transcriptional signature. Collectively, these findings demonstrate that a critical, and perhaps minor, subset of IL-2-dependent targets is indexed to a low IL-2R signaling threshold and that a substantial proportion of the Treg cell gene program is regulated by IL-2.
引用
收藏
页码:204 / 217
页数:14
相关论文
共 50 条
  • [1] CARMA1 Regulation of Regulatory T Cell Development Involves Modulation of Interleukin-2 Receptor Signaling
    Lee, Andrew Joon
    Wu, Xuefeng
    Cheng, Hanyin
    Zhou, Xiaofei
    Cheng, Xuhong
    Sun, Shao-Cong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (21) : 15696 - 15703
  • [2] Cytokine Signaling in the Development and Homeostasis of Regulatory T cells
    Toomer, Kevin H.
    Malek, Thomas R.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (03):
  • [3] A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis
    Chawla, Amanpreet Singh
    Khalsa, Jasneet Kaur
    Dhar, Atika
    Gupta, Suman
    Umar, Danish
    Arimbasseri, Gopalakrishnan Aneeshkumar
    Bal, Vineeta
    George, Anna
    Rath, Satyajit
    IMMUNOLOGY, 2020, 160 (03) : 295 - 309
  • [4] Interleukin-2 receptor signaling acts as a checkpoint that influences the distribution of regulatory T cell subsets
    Shouse, Acacia N.
    Villarino, Alejandro V.
    Malek, Thomas R.
    ISCIENCE, 2024, 27 (12)
  • [5] Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
    Matsuoka, Ken-ichi
    Koreth, John
    Kim, Haesook T.
    Bascug, Gregory
    McDonough, Sean
    Kawano, Yutaka
    Murase, Kazuyuki
    Cutler, Corey
    Ho, Vincent T.
    Alyea, Edwin P.
    Armand, Philippe
    Blazar, Bruce R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (179)
  • [6] Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells
    Liu, David V.
    Maier, Lisa M.
    Hafler, David A.
    Wittrup, K. Dane
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 887 - 894
  • [7] Interleukin-2 and regulatory T cells in rheumatic diseases
    Kolios, Antonios G. A.
    Tsokos, George C.
    Klatzmann, David
    NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (12) : 749 - 766
  • [8] Foxp3+ Regulatory T Cells Promote T Helper 17 Cell Development In Vivo through Regulation of Interleukin-2
    Chen, Yi
    Haines, Christopher J.
    Gutcher, Ilona
    Hochweller, Kristin
    Blumenschein, Wendy M.
    McClanahan, Terrill
    Haemmerling, Guenter
    Li, Ming O.
    Cua, Daniel J.
    McGeachy, Mandy J.
    IMMUNITY, 2011, 34 (03) : 409 - 421
  • [9] Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
    von Spee-Mayer, Caroline
    Siegert, Elise
    Abdirama, Dimas
    Rose, Angelika
    Klaus, Anika
    Alexander, Tobias
    Enghard, Philipp
    Sawitzki, Birgit
    Hiepe, Falk
    Radbruch, Andreas
    Burmester, Gerd-Ruediger
    Riemekasten, Gabriela
    Humrich, Jens Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : 1407 - 1415
  • [10] Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
    Malek, Thomas R.
    Castro, Iris
    IMMUNITY, 2010, 33 (02) : 153 - 165